JP2005507891A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005507891A5 JP2005507891A5 JP2003530312A JP2003530312A JP2005507891A5 JP 2005507891 A5 JP2005507891 A5 JP 2005507891A5 JP 2003530312 A JP2003530312 A JP 2003530312A JP 2003530312 A JP2003530312 A JP 2003530312A JP 2005507891 A5 JP2005507891 A5 JP 2005507891A5
- Authority
- JP
- Japan
- Prior art keywords
- chito
- oligomer
- range
- treatment
- chain length
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 208000012659 Joint disease Diseases 0.000 claims 5
- 230000006196 deacetylation Effects 0.000 claims 5
- 238000003381 deacetylation reaction Methods 0.000 claims 5
- 239000008194 pharmaceutical composition Substances 0.000 claims 5
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 claims 4
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 claims 4
- MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 claims 4
- 229950006780 n-acetylglucosamine Drugs 0.000 claims 4
- 206010039073 rheumatoid arthritis Diseases 0.000 claims 4
- 239000003814 drug Substances 0.000 claims 3
- 201000008482 osteoarthritis Diseases 0.000 claims 3
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 claims 2
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 claims 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- 208000035475 disorder Diseases 0.000 claims 2
- 229960002442 glucosamine Drugs 0.000 claims 2
- 208000027866 inflammatory disease Diseases 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 208000024891 symptom Diseases 0.000 claims 2
- 229920002101 Chitin Polymers 0.000 claims 1
- 208000025747 Rheumatic disease Diseases 0.000 claims 1
- 230000003110 anti-inflammatory effect Effects 0.000 claims 1
- 230000000552 rheumatic effect Effects 0.000 claims 1
- 230000001568 sexual effect Effects 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IS6085A IS6085A (is) | 2001-09-26 | 2001-09-26 | Lyfjablanda með kítósan óligómerum |
| PCT/IS2002/000016 WO2003026677A1 (en) | 2001-09-26 | 2002-09-26 | Pharmaceutical composition comprising chito-oligomers |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2005507891A JP2005507891A (ja) | 2005-03-24 |
| JP2005507891A5 true JP2005507891A5 (enExample) | 2006-01-12 |
| JP4613008B2 JP4613008B2 (ja) | 2011-01-12 |
Family
ID=36700489
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003530312A Expired - Lifetime JP4613008B2 (ja) | 2001-09-26 | 2002-09-26 | キト−オリゴマーを含む医薬組成物 |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US7985741B2 (enExample) |
| EP (1) | EP1435976B1 (enExample) |
| JP (1) | JP4613008B2 (enExample) |
| KR (1) | KR20040062548A (enExample) |
| AT (1) | ATE359797T1 (enExample) |
| CA (1) | CA2507926C (enExample) |
| DE (1) | DE60219653T2 (enExample) |
| DK (1) | DK1435976T3 (enExample) |
| ES (1) | ES2284935T3 (enExample) |
| IS (2) | IS6085A (enExample) |
| PT (1) | PT1435976E (enExample) |
| SI (1) | SI1435976T1 (enExample) |
| WO (1) | WO2003026677A1 (enExample) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003054208A2 (en) * | 2001-12-13 | 2003-07-03 | Ism Biopolymer Inc. | Method of modulating release of saccharides and uses thereof |
| GB0321996D0 (en) * | 2003-09-19 | 2003-10-22 | Novartis Nutrition Ag | Organic compounds |
| EP1670486A4 (en) * | 2003-10-01 | 2009-04-01 | Optimer Pharmaceuticals Inc | TREATMENT OF A CONDITION IN A MAMMALIAN WITH ADMINISTRATION OF AMINO SUGAR AND USES THEREOF |
| WO2005051326A2 (en) * | 2003-11-24 | 2005-06-09 | Optimer Pharmaceuticals, Inc. | Treatment of a condition in a mammal with administration of compounds and methods of use thereof |
| JP4496375B2 (ja) * | 2004-05-21 | 2010-07-07 | 国立大学法人鳥取大学 | 創傷の治療又は処置のための薬剤 |
| JP5632125B2 (ja) * | 2005-06-14 | 2014-11-26 | ジェニス イーエイチエフ．Ｇｅｎｉｓ ｅｈｆ． | 部分的脱アセチル化キチン誘導体の組成物 |
| US7485718B2 (en) | 2005-06-16 | 2009-02-03 | E. I. Du Pont De Nemours And Company | Chemical synthesis of low molecular weight polyglucosamines and polygalactosamines |
| WO2007001282A2 (en) * | 2005-06-16 | 2007-01-04 | E.I. Dupont De Nemours And Company | Low molecular weight polyglucosamines and polygalactosamines |
| KR100831335B1 (ko) * | 2006-06-22 | 2008-05-22 | 부경대학교 산학협력단 | 인간 피부 섬유아세포에서 메트릭스메탈로프로테이나제-2의 발현 및 활성을 억제시키는키토올리고사카라이드 화합물 및 이를 함유한 메트릭스메탈로프로테이나제-2 억제제 |
| WO2010007631A1 (en) * | 2008-07-18 | 2010-01-21 | Genis Ehf. | New composition for treating autoimmune disorders |
| KR20100060634A (ko) * | 2008-11-28 | 2010-06-07 | (주)아모레퍼시픽 | 미토콘드리아 활성화를 위한 조성물 |
| KR101729137B1 (ko) * | 2009-07-28 | 2017-04-26 | (주)아모레퍼시픽 | 키토올리고당을 함유하는 피로회복용 조성물 |
| MX368764B (es) | 2011-06-03 | 2019-10-15 | Maguire Abbey Llc | Método, composición, y artículos para mejorar la lubricación de articulación. |
| AR090026A1 (es) | 2011-09-08 | 2014-10-15 | Novozymes Bioag As | Metodos y composiciones para tratamiento de semillas |
| EP2748123B1 (en) | 2011-09-14 | 2023-11-08 | Novozymes Bioag A/S | Use of lipochito-oligosaccharides and/or chito oligosaccharides in combination with phosphate-solubilizing microorganisms to enhance plant growth |
| UA114299C2 (uk) | 2011-09-23 | 2017-05-25 | Новозаймс Біоаг А/С | Хітоолігосахариди та способи застосування при стимулюванні росту рослин |
| MX2014003411A (es) * | 2011-09-23 | 2015-03-19 | Novozymes Bioag As | Quitooligosacaridos y metodos para el uso en el mejoramiento del crecimiento del maiz. |
| CN104470550A (zh) | 2012-04-23 | 2015-03-25 | 杰尼斯公共有限公司 | 作为骨移植替代物的含有部分脱乙酰壳多糖的自硬化生物活性接合剂组合物 |
| JP6285497B2 (ja) * | 2016-06-07 | 2018-02-28 | 株式会社エバーライフ | 鶏冠抽出物含有経口組成物及び鶏冠抽出物の香味に由来する摂取困難性の改善方法 |
| KR101673368B1 (ko) | 2016-07-14 | 2016-11-08 | 김기혁 | 공정가스 반응물의 콜드트랩 장치 |
| WO2023205718A2 (en) * | 2022-04-21 | 2023-10-26 | Hassan Ameer E | Methods of treating inflammation |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5919122B2 (ja) * | 1976-10-12 | 1984-05-02 | 味の素株式会社 | 水溶性部分脱アセチル化キチン及びその製造法 |
| US4532134A (en) * | 1981-04-06 | 1985-07-30 | Malette William Graham | Method of achieving hemostasis, inhibiting fibroplasia, and promoting tissue regeneration in a tissue wound |
| JP2527317B2 (ja) * | 1986-12-19 | 1996-08-21 | ライオン株式会社 | 骨疾患治療剤 |
| US6184037B1 (en) * | 1996-05-17 | 2001-02-06 | Genemedicine, Inc. | Chitosan related compositions and methods for delivery of nucleic acids and oligonucleotides into a cell |
| DE69733089T2 (de) * | 1996-12-13 | 2005-09-29 | Lescarden Inc. | Behandlung der osteoarthritis durch verabreichung von poly-n-acetyl-d-glucosamin |
| JP3062592B2 (ja) * | 1997-05-30 | 2000-07-10 | 農林水産省食品総合研究所長 | ２−アセチルアミノ−４−Ｏ−（２−アミノ−２−デオキシ−β−Ｄ −グルコピラノシル）−２−デオキシ−Ｄ −グルコースおよびその塩の製造法 |
| US6492350B2 (en) * | 2000-01-27 | 2002-12-10 | Jdc (Hawaii) Inc. | Chitin oligosaccharides and/or chitosan oligosaccharides for preventing or treating common cold or treating pain |
| EP1127574A1 (en) * | 2000-02-22 | 2001-08-29 | Food Industry Research and Development Institute | Use of chitinous materials for inhibiting cellular nitric oxide production |
| CA2313836C (en) * | 2000-03-15 | 2009-06-09 | Cargill, Incorporated | Chitosan and method of preparing chitosan |
| US20020119949A1 (en) * | 2001-02-26 | 2002-08-29 | Asa Hellman | Prophylactic teat treatment |
| JP5632125B2 (ja) | 2005-06-14 | 2014-11-26 | ジェニス イーエイチエフ．Ｇｅｎｉｓ ｅｈｆ． | 部分的脱アセチル化キチン誘導体の組成物 |
-
2001
- 2001-09-26 IS IS6085A patent/IS6085A/is unknown
-
2002
- 2002-09-26 KR KR10-2004-7004323A patent/KR20040062548A/ko not_active Ceased
- 2002-09-26 ES ES02777769T patent/ES2284935T3/es not_active Expired - Lifetime
- 2002-09-26 AT AT02777769T patent/ATE359797T1/de active
- 2002-09-26 DK DK02777769T patent/DK1435976T3/da active
- 2002-09-26 CA CA2507926A patent/CA2507926C/en not_active Expired - Lifetime
- 2002-09-26 SI SI200230558T patent/SI1435976T1/sl unknown
- 2002-09-26 JP JP2003530312A patent/JP4613008B2/ja not_active Expired - Lifetime
- 2002-09-26 PT PT02777769T patent/PT1435976E/pt unknown
- 2002-09-26 EP EP02777769A patent/EP1435976B1/en not_active Expired - Lifetime
- 2002-09-26 WO PCT/IS2002/000016 patent/WO2003026677A1/en not_active Ceased
- 2002-09-26 DE DE60219653T patent/DE60219653T2/de not_active Expired - Lifetime
- 2002-09-26 US US10/490,637 patent/US7985741B2/en active Active
-
2004
- 2004-03-22 IS IS7193A patent/IS2783B/is unknown
-
2011
- 2011-06-20 US US13/164,397 patent/US8415326B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005507891A5 (enExample) | ||
| CA2507926A1 (en) | Pharmaceutical composition comprising chito-oligomers | |
| ES2940891T3 (es) | Composición de fibra dietética | |
| JP2006502129A (ja) | 腎臓濾過および腎臓通過中のリソソーム分解に対して耐性を示す抗微生物性荷電ポリマー、その組成物および使用方法 | |
| EP1614431A3 (en) | Compositions for treatment of disorders of the oesophagus | |
| JP2012506904A5 (enExample) | ||
| JP2003522796A5 (enExample) | ||
| JP2006502129A5 (enExample) | ||
| NZ624749A (en) | A sulfated polysaccharide compound and the preparation and use thereof | |
| US6492350B2 (en) | Chitin oligosaccharides and/or chitosan oligosaccharides for preventing or treating common cold or treating pain | |
| JP2006516988A (ja) | 持続した薬物放出またはムコ粘着のための活性剤およびキトサンを含む製薬組成物 | |
| JP2009501801A5 (enExample) | ||
| MX2009000459A (es) | Suspensiones farmaceuticas que comprenden fenilefrina y metodo de preparacion. | |
| US20050009782A1 (en) | Antiviral charged polymers that exhibit resistance to lysosomal degradation during kidney filtration and renal passage, compositions and methods of use thereof | |
| KR20110017819A (ko) | 소화성 궤양과 십이지장 궤양 치료 및 예방을 위한 히알루론산 혼합물 | |
| JP2012526099A5 (enExample) | ||
| CN101278933A (zh) | 一种含有二甲啡烷的药物组合物及其制备方法 | |
| EP2040716B1 (en) | Cellulose sulfate for the treatment of rhinovirus infection | |
| JP2010518075A5 (enExample) | ||
| AU2015261841B2 (en) | Aqueous gel composition and its use | |
| CN101068530A (zh) | 无染料药物悬浮液和相关方法 | |
| RU2004118493A (ru) | Фармацевтическая суспензия для перорального применения | |
| CN214513656U (zh) | 一种生物制药厂胶囊生产废气净化装置 | |
| CN102349883A (zh) | 对乙酰氨基酚口腔速溶膜及其制备方法 | |
| JP2008308430A5 (enExample) |